Signaling Networks and Cell Cycle Control

• 1 Integrin Signaling.- 2 Signal Transduction Through Tyrosine Kinase Growth Factor Receptors.- 3 Signaling from TGF-? Receptors.- 4 The Wnt Signal Transduction Pathway.- 5 Signaling from G-Protein-Coupled Receptors to the Nucleus.- 6 Proximal Events in T-Cell Activation.- 7 Signal Transduction from the High Affinity IgE Receptor.- 8 Signaling Through Fas (CD95, APO-1) and Related Death Receptors.- 9 Signal Transduction to the Nucleus by MAP Kinase.- 10 The Regulation of MAP Kinase Pathways by MAP Kinase Phosphatases.- 11 Control of MAPK Signaling by Ste20- and Stel 1-Like Kinases.- 12 Ras Signaling and Transformation.- 13 Signaling Pathways Controlled by Rho Family GTP-Binding Proteins.- 14 PI3-Kinases: Role in Signal Transduction.- 15 PI3K-Related Kinases: Roles in Cell-Cycle Regulation and DNA Damage Responses.- 16 Integrative Signaling Through c-Abl: A Tyrosine Kinase with Nuclear and Cytoplasmic Functions.- 17 Src: A Model for Regulation of Intracellular Signaling Molecules.- 18 Inhibitors of Protein Kinase C and Related Receptors for the Lipophilic Second Messenger sn-1,2-Diacylglycerol.- 19 Reactive Oxygen Species in Proliferative Signaling.- 20 Sphingolipid Metabolites in Signal Transduction.- 21 The Jak/Stat Signaling Cascade: Its Role in the Biological Effects of Interferons.- 22 Regulation of Cell Growth and Death by p53.- 23 Regulation of NF-?B Function: Novel Molecular Targets for Pharmacological Intervention.- 24 Using Protein—Interaction Domains to Manipulate Signaling Pathways.- 25 Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents.- 26 A Pharmacological Approach to the MAP Kinase Cascade.- 27 Specific Inhibitors of p38 MAP Kinase.- 28 Farnesyltransferase Inhibitors: Anti-Ras or Anticancer Drugs?.- 29 Targeted p53 Gene Therapy-MediatedRadiosensitization and Chemosensitization.- 30 Treatment of p53-Deficient Cancers by Adenovirus E1B-Region Mutants: From Basic Research to the Clinic.- 31 The Cell Cycle Inhibitor p27 as a Prognostic Marker in Human Tumors and a Novel Target for Therapeutic Intervention.- 32 Chemical Cyclin-Dependent Kinase Inhibitors: Therapeutic Implications.

"Each chapter contains a well-referenced, clearly illustrated and up-to-date summary of the state of affairs including a discussion of the areas that are still open for further work. The volume provides a good read for both workers actively engaged in drug research as well as those working in the more fundamental areas of signaling and the cell cycle." - Cell Biology and Function "...the range of topics included in this book is impressive...This volume works well on many levels. For graduate students struggling to assimilate the large body of signaling literature, the first half of the book offers what amounts to a comprehensive review of the most basic aspects of signal transduction. For experts, these same chapters serve as a point of departure for the second half, which deals with the emerging body of literature on how one can manipulate signaling pathways in the treatment of disease. It is the combination of basic and applied aspects of signal transduction that makes this book unique...the editor has done a remarkable job in selecting and assembling reviews from experts in signal transduction, and for presenting such a lucid discussion of this complex field." - Quarterly Review of Biology "Each chapter is well referenced and stands alone as a comprehensive review in a specific area of signaling networks and cell-cycle control. In many cases the authors have highlighted several areas that are still open for further investigation, and have attempted to define the most likely molecular targets for pharmacological intervention...I would recommend this as a must have reference book, aimed mainly at an expert audience, which any good academic or biotechnological company library should have." - Cell Biology International